Valuation check: 1294.TWO's profit margin is 16.22%, above the sector sector average of 13.4%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
Hantech Bio-Technology , Ltd. (1294.TWO) currently reports a profit margin of 16.22% as of September 2026. That compares with 18.45% in the prior-year period — down 12.1% year over year. That is above the sector sector average of 13.4%. Use the charts on this page to explore Hantech Bio-Technology , Ltd.'s profit margin history and peer comparisons.
Hantech Bio-Technology , Ltd.'s profit margin decreased from 18.45% to 16.22% — a 12.1% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Hantech Bio-Technology , Ltd.'s profit margin of 16.22% is higher than the its sector sector average of 13.4%. That is roughly 21.0% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Hantech Bio-Technology , Ltd.'s current 16.22% should be judged against industry norms (sector average: 13.4%) and against 1294.TWO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of 16.22%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.4%. From there, open related valuation or income-statement pages for Hantech Bio-Technology , Ltd., and consider following 1294.TWO for alerts when major investors trade the stock.